Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries

Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pain and symptom management 2014-12, Vol.48 (6), p.1135-1144
Hauptverfasser: Vranken, Marjolein J.M., PharmD, LLM, Mantel-Teeuwisse, Aukje K., PharmD, PhD, Jünger, Saskia, Dr rer medic, Radbruch, Lukas, MD, Lisman, John, PharmD, LLM, Scholten, Willem, PharmD, MPA, Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol, Lynch, Tom, PhD, Schutjens, Marie-Hélène D.B., LLM, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1144
container_issue 6
container_start_page 1135
container_title Journal of pain and symptom management
container_volume 48
creator Vranken, Marjolein J.M., PharmD, LLM
Mantel-Teeuwisse, Aukje K., PharmD, PhD
Jünger, Saskia, Dr rer medic
Radbruch, Lukas, MD
Lisman, John, PharmD, LLM
Scholten, Willem, PharmD, MPA
Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol
Lynch, Tom, PhD
Schutjens, Marie-Hélène D.B., LLM, PhD
description Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.
doi_str_mv 10.1016/j.jpainsymman.2014.02.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1634722676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0885392414002206</els_id><sourcerecordid>1634722676</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</originalsourceid><addsrcrecordid>eNqNkk2P0zAQhiMEYsvCX0DmgMQlYWznkwNSqbqA1KWCXc6W40wWd1Mn60mQet4_jkPLhzhxsjx63nfseSeKXnBIOPD89S7ZDdo6Ouz32iUCeJqASIDLB9GCl4WM84zLh9ECyjKLZSXSs-gJ0Q4AMpnLx9GZSIsSeJkuovsN3uiOvdPeW_TErGNLY5DIuhu2HWxvG3aJjTXWIb1hX5CmbiTWt2z8hmx5vb1cs8-TNbfsymg31z_p0fYueAZnS93P21xfaxrRO7aefD9gYFf95MbQlZ5Gj1rdET47nefR14v19epDvNm-_7habmKTlXKMpSlrNCIral5AhiCyKpNtXTemzdMyx6bluq0yU3NRm1ZXUJsUJOS6wRYq1PI8enX0HXx_NyGNam_JYNdph_1EiucyLYTIizyg1RE1vify2KrB2732B8VBzRmonforAzVnoECokEHQPj-1meo9Nr-Vv4YegJcnQJPRXeu1M5b-cBVkoipE4FZHDsNQvod4FBmLzoQ4PJpRNb39r-e8_cfFdNbZ0PgWD0i7fvIhrfB7RUGgrualmXeGpwBCQC5_AJhNwa0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1634722676</pqid></control><display><type>article</type><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</creator><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><description>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2014.02.013</identifier><identifier>PMID: 24780184</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>access ; Analgesics ; Analgesics, Opioid - therapeutic use ; Anesthesia &amp; Perioperative Care ; ATOME ; barriers ; Biological and medical sciences ; Drug and Narcotic Control - legislation &amp; jurisprudence ; Europe ; harm reduction ; Health Policy - legislation &amp; jurisprudence ; Humans ; legislation ; Medical sciences ; medicines ; morphine ; Neuropharmacology ; Opioids ; Pain Medicine ; pain treatment ; palliative care ; Palliative Care - legislation &amp; jurisprudence ; Pharmacology. Drug treatments ; regulations</subject><ispartof>Journal of pain and symptom management, 2014-12, Vol.48 (6), p.1135-1144</ispartof><rights>American Academy of Hospice and Palliative Medicine</rights><rights>2014 American Academy of Hospice and Palliative Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</citedby><cites>FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpainsymman.2014.02.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=29052972$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24780184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM</creatorcontrib><creatorcontrib>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creatorcontrib><creatorcontrib>Jünger, Saskia, Dr rer medic</creatorcontrib><creatorcontrib>Radbruch, Lukas, MD</creatorcontrib><creatorcontrib>Lisman, John, PharmD, LLM</creatorcontrib><creatorcontrib>Scholten, Willem, PharmD, MPA</creatorcontrib><creatorcontrib>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creatorcontrib><creatorcontrib>Lynch, Tom, PhD</creatorcontrib><creatorcontrib>Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</description><subject>access</subject><subject>Analgesics</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Anesthesia &amp; Perioperative Care</subject><subject>ATOME</subject><subject>barriers</subject><subject>Biological and medical sciences</subject><subject>Drug and Narcotic Control - legislation &amp; jurisprudence</subject><subject>Europe</subject><subject>harm reduction</subject><subject>Health Policy - legislation &amp; jurisprudence</subject><subject>Humans</subject><subject>legislation</subject><subject>Medical sciences</subject><subject>medicines</subject><subject>morphine</subject><subject>Neuropharmacology</subject><subject>Opioids</subject><subject>Pain Medicine</subject><subject>pain treatment</subject><subject>palliative care</subject><subject>Palliative Care - legislation &amp; jurisprudence</subject><subject>Pharmacology. Drug treatments</subject><subject>regulations</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk2P0zAQhiMEYsvCX0DmgMQlYWznkwNSqbqA1KWCXc6W40wWd1Mn60mQet4_jkPLhzhxsjx63nfseSeKXnBIOPD89S7ZDdo6Ouz32iUCeJqASIDLB9GCl4WM84zLh9ECyjKLZSXSs-gJ0Q4AMpnLx9GZSIsSeJkuovsN3uiOvdPeW_TErGNLY5DIuhu2HWxvG3aJjTXWIb1hX5CmbiTWt2z8hmx5vb1cs8-TNbfsymg31z_p0fYueAZnS93P21xfaxrRO7aefD9gYFf95MbQlZ5Gj1rdET47nefR14v19epDvNm-_7habmKTlXKMpSlrNCIral5AhiCyKpNtXTemzdMyx6bluq0yU3NRm1ZXUJsUJOS6wRYq1PI8enX0HXx_NyGNam_JYNdph_1EiucyLYTIizyg1RE1vify2KrB2732B8VBzRmonforAzVnoECokEHQPj-1meo9Nr-Vv4YegJcnQJPRXeu1M5b-cBVkoipE4FZHDsNQvod4FBmLzoQ4PJpRNb39r-e8_cfFdNbZ0PgWD0i7fvIhrfB7RUGgrualmXeGpwBCQC5_AJhNwa0</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Vranken, Marjolein J.M., PharmD, LLM</creator><creator>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creator><creator>Jünger, Saskia, Dr rer medic</creator><creator>Radbruch, Lukas, MD</creator><creator>Lisman, John, PharmD, LLM</creator><creator>Scholten, Willem, PharmD, MPA</creator><creator>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creator><creator>Lynch, Tom, PhD</creator><creator>Schutjens, Marie-Hélène D.B., LLM, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141201</creationdate><title>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</title><author>Vranken, Marjolein J.M., PharmD, LLM ; Mantel-Teeuwisse, Aukje K., PharmD, PhD ; Jünger, Saskia, Dr rer medic ; Radbruch, Lukas, MD ; Lisman, John, PharmD, LLM ; Scholten, Willem, PharmD, MPA ; Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol ; Lynch, Tom, PhD ; Schutjens, Marie-Hélène D.B., LLM, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-3c8bec257b1705e025953fbbdcf6486edf1af95cb12bcfa90bc40306adef09ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>access</topic><topic>Analgesics</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Anesthesia &amp; Perioperative Care</topic><topic>ATOME</topic><topic>barriers</topic><topic>Biological and medical sciences</topic><topic>Drug and Narcotic Control - legislation &amp; jurisprudence</topic><topic>Europe</topic><topic>harm reduction</topic><topic>Health Policy - legislation &amp; jurisprudence</topic><topic>Humans</topic><topic>legislation</topic><topic>Medical sciences</topic><topic>medicines</topic><topic>morphine</topic><topic>Neuropharmacology</topic><topic>Opioids</topic><topic>Pain Medicine</topic><topic>pain treatment</topic><topic>palliative care</topic><topic>Palliative Care - legislation &amp; jurisprudence</topic><topic>Pharmacology. Drug treatments</topic><topic>regulations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vranken, Marjolein J.M., PharmD, LLM</creatorcontrib><creatorcontrib>Mantel-Teeuwisse, Aukje K., PharmD, PhD</creatorcontrib><creatorcontrib>Jünger, Saskia, Dr rer medic</creatorcontrib><creatorcontrib>Radbruch, Lukas, MD</creatorcontrib><creatorcontrib>Lisman, John, PharmD, LLM</creatorcontrib><creatorcontrib>Scholten, Willem, PharmD, MPA</creatorcontrib><creatorcontrib>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</creatorcontrib><creatorcontrib>Lynch, Tom, PhD</creatorcontrib><creatorcontrib>Schutjens, Marie-Hélène D.B., LLM, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vranken, Marjolein J.M., PharmD, LLM</au><au>Mantel-Teeuwisse, Aukje K., PharmD, PhD</au><au>Jünger, Saskia, Dr rer medic</au><au>Radbruch, Lukas, MD</au><au>Lisman, John, PharmD, LLM</au><au>Scholten, Willem, PharmD, MPA</au><au>Payne, Sheila, BA (Hons), RN, DipN, PhD, Cpsychol</au><au>Lynch, Tom, PhD</au><au>Schutjens, Marie-Hélène D.B., LLM, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>48</volume><issue>6</issue><spage>1135</spage><epage>1144</epage><pages>1135-1144</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><abstract>Abstract Context Overregulation of controlled medicines is one of the factors contributing to limited access to opioid medicines. Objectives The purpose of this study was to identify legal barriers to access to opioid medicines in 12 Eastern European countries participating in the Access to Opioid Medication in Europa project, using a quick scan method. Methods A quick scan method to identify legal barriers was developed focusing on eight different categories of barriers. Key experts in 12 European countries were requested to send relevant legislation. Legislation was quick scanned using World Health Organization guidelines. Overly restrictive provisions and provisions that contain stigmatizing language and incorrect definitions were identified. The selected provisions were scored into two categories: 1) barrier and 2) uncertain, and reviewed by two authors. A barrier was recorded if both authors agreed the selected provision to be a barrier (Category 1). Results National legislation was obtained from 11 of 12 countries. All 11 countries showed legal barriers in the areas of prescribing (most frequently observed barrier). Ten countries showed barriers in the areas of dispensing and showed stigmatizing language and incorrect use of definitions in their legislation. Most barriers were identified in the legislation of Bulgaria, Greece, Lithuania, Serbia, and Slovenia. The Cypriot legislation showed the fewest total number of barriers. Conclusion The selected countries have in common as main barriers prescribing and dispensing restrictions, the use of stigmatizing language, and incorrect use of definitions. The practical impact of these barriers identified using a quick scan method needs to be validated by other means.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>24780184</pmid><doi>10.1016/j.jpainsymman.2014.02.013</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3924
ispartof Journal of pain and symptom management, 2014-12, Vol.48 (6), p.1135-1144
issn 0885-3924
1873-6513
language eng
recordid cdi_proquest_miscellaneous_1634722676
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects access
Analgesics
Analgesics, Opioid - therapeutic use
Anesthesia & Perioperative Care
ATOME
barriers
Biological and medical sciences
Drug and Narcotic Control - legislation & jurisprudence
Europe
harm reduction
Health Policy - legislation & jurisprudence
Humans
legislation
Medical sciences
medicines
morphine
Neuropharmacology
Opioids
Pain Medicine
pain treatment
palliative care
Palliative Care - legislation & jurisprudence
Pharmacology. Drug treatments
regulations
title Legal Barriers in Accessing Opioid Medicines: Results of the ATOME Quick Scan of National Legislation of Eastern European Countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T08%3A41%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Legal%20Barriers%20in%20Accessing%20Opioid%20Medicines:%20Results%20of%20the%20ATOME%20Quick%20Scan%20of%20National%20Legislation%20of%20Eastern%20European%20Countries&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Vranken,%20Marjolein%20J.M.,%20PharmD,%20LLM&rft.date=2014-12-01&rft.volume=48&rft.issue=6&rft.spage=1135&rft.epage=1144&rft.pages=1135-1144&rft.issn=0885-3924&rft.eissn=1873-6513&rft_id=info:doi/10.1016/j.jpainsymman.2014.02.013&rft_dat=%3Cproquest_cross%3E1634722676%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1634722676&rft_id=info:pmid/24780184&rft_els_id=S0885392414002206&rfr_iscdi=true